Amrutanjan Health Care Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 7.08% vs 10.68% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 18.31% vs 72.26% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 21.54% vs 98.83% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -16.67% vs 100.00% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Amrutanjan Healt With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

117.70

90.33

27.37

30.30%

Other Operating Income

0.00

Total Operating income

117.70

90.33

27.37

30.30%

Raw Material Cost

25.12

0.00

25.12

Purchase of Finished goods

35.19

54.08

-18.89

-34.93%

(Increase) / Decrease In Stocks

-2.66

-3.56

0.90

25.28%

Employee Cost

15.95

5.30

10.65

200.94%

Power Cost

0.00

Manufacturing Expenses

0.01

0.00

0.01

Selling and Distribution Expenses

13.75

0.00

13.75

Other Expenses

13.81

10.63

3.18

29.92%

Total Expenditure (Excl Depreciation)

101.17

66.45

34.72

52.25%

Operating Profit (PBDIT) excl Other Income

16.53

23.88

-7.35

-30.78%

Other Income

4.30

9.40

-5.10

-54.26%

Operating Profit (PBDIT)

20.83

33.28

-12.45

-37.41%

Interest

0.05

0.11

-0.06

-54.55%

Exceptional Items

0.00

Gross Profit (PBDT)

20.78

33.17

-12.39

-37.35%

Depreciation

1.56

0.52

1.04

200.00%

Profit Before Tax

19.21

32.65

-13.44

-41.16%

Tax

5.25

8.43

-3.18

-37.72%

Provisions and contingencies

0.00

Profit After Tax

13.96

24.22

-10.26

-42.36%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

13.96

24.22

-10.26

-42.36%

Equity Capital

2.89

12.34

-9.45

-76.58%

Face Value

1.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

4.83

9.81

-4.98

-50.76%

Diluted Earnings per share

4.83

9.81

-4.98

-50.76%

Operating Profit Margin (Excl OI)

14.04%

26.44%

0.00

-12.40%

Gross Profit Margin

17.66%

36.72%

0.00

-19.06%

PAT Margin

11.86%

26.81%

0.00

-14.95%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 117.70 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 25.15% vs -30.54% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 7.08% vs 10.68% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 13.96 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 67.99% vs -45.26% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 18.31% vs 72.26% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 16.53 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 95.62% vs -52.26% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 21.54% vs 98.83% in Sep 2024

Quarterly - Interest

Interest 0.05 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 25.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -16.67% vs 100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 14.04%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024